• 제목/요약/키워드: Liver dose

검색결과 1,419건 처리시간 0.026초

흉부 X-ray 검사 시 선량 비교를 활용한 유효 Detector Exposure Index 기반의 적절한 관전압 범위 제안 (Investigation of Tube Voltage Range using Dose Comparison based on Effective Detector Exposure Index in Chest Radiography)

  • 심지나;이영진
    • 한국방사선학회논문지
    • /
    • 제15권2호
    • /
    • pp.139-145
    • /
    • 2021
  • 본 연구는 흉부 X-ray 검사 시 디지털 영상의 적절한 유효 Detector exposure index (DEI) 범위 내의 영상의 Dose area product (DAP)값과 유효선량을 비교함으로써 적절한 관전압의 범위를 확인하고자 하였다. GE Definium 8000을 사용하여 흉부팬텀을 이용한 Chest PA 검사를 재현하였다. kVp range는 60~130 kVp, mAs range는 2.5 ~ 40 mAs로 설정하였다. 획득한 영상을 유효한 DEI 범위의 영상으로 분류하고 측정한 DAP을 이용하여 PC-Based Monte Carlo Program을 통해 유효선량을 계산하였다. 영상의 정량적 평가를 하기 위해 Picture archiving and communication system을 이용하여 흉추, 갈비뼈가 포함된 폐야부위, 갈비뼈가 포함되지 않은 폐야부위, 간 등 총 네 부분의 Signal to noise ratio (SNR)를 측정하였다. 관전압 별 그룹의 유의성은 Kruskal-wallis test와 사후검정으로 Mann-whitney test를 시행하여 검증하였으며 검증에 사용된 신뢰구간은 95%이다. 총 13개의 관전압 중 적정한 유효 DEI 범위안에 포함된 네개의 관전압 (60~90 kVp)을 각각 비교하였을 때, DAP는 60 kVp를 기준으로 80 kVp, 90 kVp를 비교한 결과에서만 유의한 차이를 보였다 (p= 0.034, 0.021). 유효선량은 모든 관전압 그룹에서 유의한 차이를 보이지 않았다 (p>0.05). SNR은 간 부위에서 80 kVp와 90 kVp를 제외한 모든 그룹에서 유의한 차이를 보였다 (p<0.05). 그러므로 디지털 환경에서 적정한 흉부 X-ray 영상의 농도를 나타내기 위해 100 kVp 이상의 고관전압은 환자 선량 및 영상 측면에서 재고할 필요성이 있다고 사료된다.

Nutritional Value and Bioactive Properties of Enzymatic Hydrolysates prepared from the Livers of Oncorhynchus keta and Oncorhynchus gorbuscha (Pacific Salmon)

  • Yoon, Ho Dong;Karaulova, Ekaterina P.;Shulgina, Lilia V.;Yakush, Evgeni V.;Mok, Jong Soo;Lee, Su Seon;Xie, Chengliang;Kim, Jeong Gyun
    • Fisheries and Aquatic Sciences
    • /
    • 제18권1호
    • /
    • pp.13-20
    • /
    • 2015
  • Calculated chemical scores (computed in relation to the FAO/WHO reference protein) for salmon liver protein hydrolysates indicated that all amino acids (other than methionine and threonine) were present in adequate or excess quantities; thus, the raw liver material is a good source of essential amino acids. The hydrophobic amino acids contents in hydrolysates prepared from Oncorhynchus keta and O. gorbuscha were 38.4 and 39.1%, respectively. The proportion of released peptides exceeding 500 kDa was reduced when hydrolysates were treated with the commercial enzyme Alcalase, although proportions in the following MW ranges were elevated: 100-500 kDa and <50 kDa. The optimal conditions for enzymatic hydrolysis were as follows: pH 7.0, $50^{\circ}C$, and a reaction time of 1 h. Of the different proteases tested, Alcalase was the most efficient for production of salmon liver hydrolysate with the highest 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenging activity. The hydrolysates prepared from salmon liver had a balanced amino acid composition. The liver protein hydrolysates contained low molecular weight peptides, some of which may be bio-active; this bio-active potential should be investigated. Inhibition of the DPPH radical increased with increased degree of hydrolysis (DH), regardless of protease type. DPPH radical scavenging abilities, antithrombotic effects and ${\alpha}$-glucosidase enzyme inhibition effects of O. keta liver hydrolysate increased in a dose-dependent manner. Thus, salmon liver hydrolysate may be useful in functional food applications and as a source of novel products.

The Serum or Urinary Levels of Cyclohexane Metabolites in Liver Damaged Rats

  • 조현성
    • 대한의생명과학회지
    • /
    • 제12권3호
    • /
    • pp.241-247
    • /
    • 2006
  • To evaluate an effect of pathological liver damage on the cyclohexane (CH) metabolism, rats were pretreated with 50% carbon tetrachloride $(CCl_4)$ dissolved in olive oil (0.1ml/100g body weight) 10 or 17 times intraperitoneally at intervals of every other day. To these liver damaged animals, CH (a single dose of 1.56g/kg body weight, i.p.) was administered at 48hr after the last injection of $CCl_4$. The CH metabolites; cyclohexanol (CH-ol), cyclohexane-l,2-diol (CH-l,2-diol) and cyclohexane-l,4-diol (CH-l,4-diol) and cyclohexanone (CH-one) were detected in the urine of CH treated rats. After CH treatment, the serum levels of CH-ol and CH-one were remarkably increased at 4 hr and then decreased at 8hr in normal group. Whereas in liver damaged rats, these CH metabolites were higher at 8hr than at 4hr. The excretion rate of CH metabolites trom serum into urine was more decreased in liver damaged animals than normal group, with the levels of excretion rate being lower in $CCl_4$ 17 times injected animals than 10 times injected ones. It was interesting that the urinary concentration of CH metabolites was generally more increased in liver damaged animals than normal ones, and the increasing rate was higher in $CCl_4$ 17 times injected rats than 10 times injected ones. Taken all together, it is assumed that reduced urinary excretion rate of CH metabolites in liver damaged rats might be resulted from deteriorated hepatic and renal blood flow, and an increased urinary excretion amount of CH metabolites in liver damaged rats might be caused by reduced expiration amount of the metabolites due to lung damage.

  • PDF

투시 조영 검사 시 확대율에 따른 피폭선량에 관한 고찰 (Study on Radiation dose in according to Magnification's rate in fluoroscopy)

  • 강경미;홍선숙;성민숙;손운흥
    • 대한디지털의료영상학회논문지
    • /
    • 제15권2호
    • /
    • pp.39-44
    • /
    • 2013
  • Purpose : The purpose of this study is the magnification rates depending on the area of patient dose (DAP) and glass dosimeter see the change of the dose according to the dose characteristics of low-magnification aims to raise standards. Materials and Method : Direct DR equipment Sonialvision DAR-8000f, Shimadzu was used, the patient entrance dose measurements to the surface of the Rando Phantom of the neck and the abdomen was placed on the Xi unfors. glass dosimeter for measuring organ doses at the same time the Rando Phantom of the major organs in place by inserting a 9 ", 12", 15 ", 17" and 30 seconds for each magnification were measured according in fluoroscopy. DAP meter area of the patient dose was measured. Result : Esophagography at 17" 143% than 9"magnification the average area dose was increased. Organ dose of Esophagography at 17" was decreased 25.32% than 9" magnification. UGI at 17" was increased 129.73% DAP than 9" magnification. Organ dose of UGI at 17" was decreased 23.32% than 9" magnification. Where the major organs of magnification at 17" were decreased(lung -25.96%, stomach -33.09%, spleen -27.81%, liver -4.92%) than 9" magnification. Conclusion : Expected to get better quality image While using the proper magnification, and have recognition that difference Organ doses and DAP meter in fluoroscopy.

  • PDF

서양의학 독성학의 기본적 개념 및 한약의 $LD_{50}$ (Basic Concepts of Western Medicine Toxicology and $LD_{50}$ in Herbal Drugs)

  • 박영철;이선동;박경식
    • 대한예방한의학회지
    • /
    • 제3권2호
    • /
    • pp.91-100
    • /
    • 1999
  • Today, toxicology is used for many purpose, in many fields. Classification of special toxic effect is related next 4 important principles. 1. The chemical substance must move to target organ or tissue that can induce Biological effect. For this movement, we have to understand the physical-chemical characteristic of substance, and the rout of absorption, metabolism, diffusion and excretion of toxic substance. 2. Every biological effect that induced by chemical substance is not harmful. For example, some specific chemical substance is not harmful in liver enzyme system. 3. The strength of biological effect induced by chemical substance is deep related with dose. Nearly all substance is not effective below the specific dose, and it may toxic to death over the specific dose. It is the 'Dose - response relationship' But carcinogen may toxic whether it is law dose or not. 4. The information that was obtained by experimental animal test, could have to adapt in human biology. Because biological effect of chemical substance could be different in every biological species. In past, drugs was obtained by animal or plants. But in the future, it could be obtained by biochemistry, and genome project. Therefore, in Oriental medicine, research and approach is needed at this time, and have to develop new method of experience in toxic method.

  • PDF

『상한론(傷寒論)』 처방에서 감초(甘草) 용량의 안전성 및 임상 사용에 대한 문헌 고찰 (A Study for Safe Dose and Clinical Use of Glycyrrhizae Radix in Shanghanlun)

  • 김형섭;이숭인
    • 대한상한금궤의학회지
    • /
    • 제8권1호
    • /
    • pp.1-23
    • /
    • 2016
  • Objectives : The purpose of this paper is to find out the safe dose and clinical use for administration of Glycyrrhizae Radix in Shanghanlun(傷寒論). Methods : Web-databases(OASIS, NDSL, Pubmed, Google) were searched with keywords including 'Licorice', 'Pseudoaldosteronism', 'Glycyrrhizin', 'Testosterone' on 14/10/2016. The searched about 40 papers and books were reveiwed. Results : Glycyrrhizin(GL) and 3-monoglucuronyl glycyrrhetinic acid(3MGA) in Glycyrrhizae Radix are found to be the main compounds vulnerable for inducing pseudoaldosteronism. The dose range of Glycyrrhizae Radix in Shanghanlun prescriptions is from 0.25 g to 12 g as a daily administration, and this dose satisfies the guidelines of WHO, European Union, ABC etc. And risk factors contributing for personal sensitivities are old age(>60), female sex, liver dysfunction, hypokalemia, prolonged gastrointestinal transit time, anorexia nervosa, decreased 11-${\ss}$-hydroxysteroid dehydrogenase-2 activity and hypertension. Conclusions : As a result, dose of Glycyrrhizae Radix in Shanghanlun(傷寒論) is safe. However, the personal sensitivity and unexpected drug interactions are independent from doses of GL, so doctors should monitor those risk factors and symptoms of pseudoaldosteronism when administering Glycyrrhizae Radix.

유방암의 근접치료 시 수학적 모의피폭체를 이용한 인접장기의 선량평가 (Radiation Dose Calculation using MIRD TYPE PHANTOM in the Surrounding Organs during Brachytherapy of Breast Cancer)

  • 박은태;김정훈;임인철
    • 한국방사선학회논문지
    • /
    • 제10권4호
    • /
    • pp.271-278
    • /
    • 2016
  • 본 연구는 유방암의 근접치료 시 수학적 모의피폭체를 이용하여 유방 및 인접장기의 선량을 평가하고자 하였다. 좌측 유방과 우측 유방을 선원으로 설정하여 $^{192}Ir$$^{103}Pd$ 핵종에 대한 흡수선량을 분석하였다. 그 결과 선원 장기에 대한 선량은 $^{192}Ir$$^{103}Pd$에 비해 높은 흡수선량을 보였으며, 반대측 유방의 선량도 $^{192}Ir$이 높게 나타났다. 또한 유방암의 근접치료 시 특히 유의해야 할 인접장기는 폐, 간, 심장, 반대측 유방으로 평가되었다.

Bioavailabilities of Omeprazole Administered to Rats through Various Routes

  • Choi, Mi-Sook;Lee, Young-Hee;Shim, Chang-Koo
    • Archives of Pharmacal Research
    • /
    • 제18권3호
    • /
    • pp.141-145
    • /
    • 1995
  • Omeprazole, a proton pump inhibitor, was given intravenously (iv), orally (po), intraperitoneally (ip), hepatoportalvenously (pv), and intrarectally (ir) to rats at a dose of 72mg/kg in order to investigate the bioavailability of the drug, The extent of bioavailabilities of omeprazole administered through pv, ip, po, and ir routes were 88.5, 79.4, 40,8, and 38.7%, respectively. Pharmacokinetic analysis in this study and literatures (Regardh et al., 1985 : Watanabe et al., 1994) implied significant dose-dependency in hepatic first-pass metabolism, clearance and distribution, and acidic degradation in gastric fluid. The high bioavailability from the pv administration (88.5%) means that only 11.5% of dose was extracted by the first-pass metabolism through the liver at this dose (72 mg/kg). The low bioavailability from the oral administration (40.8%) in spite of minor hepatic first-pass extraction indicates low transport of the drug from GI lumen to portal vein. From the literature (Pilbrant and Cederberg, 1985), acidic degradation in gastric fluid was considered to be the major cause of the low transport. Thus, enteric coating of oral preparations would enhance the oral bioavailability substantially. The bioavailability of the drug from the rectal route, in which acidic degradation and hepatic first-pass metabolism may not occur, was low (38.7%) but comparable to that from the oral route (40.8 %) indicating poor transport across the rectal membrane. In this case, addition of an appropriate absorption enhancer would improve the bioavailability. Rectal route seems to be an possible alternative to the conventional oral route for omeprazole administration.

  • PDF

동의보감(東醫寶鑑) 중 석고(石膏)가 주약(主藥)으로 배오(配伍)된 방제(方劑)의 활용(活用)에 대한 고찰(考察) (A Study on Application of Gypsum Main Blended Prescription From Dongeuibogam)

  • 오황;이장천
    • 대한한의학방제학회지
    • /
    • 제15권1호
    • /
    • pp.1-19
    • /
    • 2007
  • This study was investigated to make sure the range of Gypsum treatment, the nature of disease, the pathology and the dosage of it in Dongeuybogam. The following conclusions were reached through investigations on the prescriptions that use Gypsum as a key ingredient. The Gypsum blended prescriptions are utilized in 23 fields of treatment such as cold, head. ect. Prescriptions that use Gypsum as the main ingredient are used commonly in the treatment of cold, head disease, fever, skin disease, diabetes, stroke, ophthalmic disease, jaundice, ENT disease and dental disease. The Gypsum is used for nature of disease which of cold, heat(fever), summer heat, phlegm, malfunction of liver, malfunction of liver and kidney, heat of stomach, malfunction of spleen and fever of stomach. The clinical dosage of Gypsum has ranged at a wide variety of amount from 1.6g to 16g per dose with 4g ${\sim}$ 8g being the typical dose for most treatment. The Gypsum is applied as a fundamental prescription with several herb remedies for the pathology.

  • PDF

Urosodeoxycholic Acid Therapy in a Child with Trimethoprim- Sulfamethoxazole-induced Vanishing Bile Duct Syndrome

  • Cho, Hyun Jeong;Jwa, Hye Jeong;Kim, Kyu Seon;Gang, Dae Yong;Kim, Jae Young
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제16권4호
    • /
    • pp.273-278
    • /
    • 2013
  • We present a case of a 7-year-old boy who had cholestasis after trimethoprim-sulfamethoxazole combination therapy. Liver biopsy was performed 36 days after the onset of jaundice because of no evidence of improving cholestasis. Liver histology revealed portal inflammation, bile plug, and biliary stasis around the central vein with the loss of the interlobular bile ducts. Immunohistochemical stains for cytokeratin 7 and 19 were negative. These findings were consistent with those of vanishing bile duct syndrome (VBDS). Chlestasis was progressively improved with dose increment of urosodeoxycholic acid from conventional to high dose. This is the first case report of trimethoprime-sulfamethoxazole associated VBDS in Korean children. The case suggests that differential diagnosis of VBDS should be considered in case of progressive cholestatic hepatitis with elevation of alkaline phosphatase and gamma-glutamyl transpeptidase after or during taking medicine to treat nonhepatobiliary diseases illness.